Search - Prime Therapeutics

411 Results for GLP-1 Pipeline Update

Managed Healthcare Executive: Prime Therapeutics Finds No Medical Cost Offsets for GLP-1 Obesity Drugs | AMCP Annual 2025

Managed Healthcare Executive: A Prime Therapeutics analysis of real-world data has found that medical costs for patients taking GLP-1 drugs for obesity had increased by about $1,338 per member,...

PA Sub-Categories: GLP-1 Prime Article: In the News
AMCP 2024: Behind the GLP-1 Spotlight Session with Ben Urick

Urick, senior principal health outcomes researcher, shares more about his Spotlight Session at the Academy of Managed Care Pharmacy (AMCP)’s Annual Meeting

PA Sub-Categories: GLP-1 Prime Article: Stories
LISTEN NOW: Get the Skinny on GLP-1s: Part 2 — Pharmacy Friends podcast

In this second of a two-part episode of the Pharmacy Friends podcast, industry experts discuss clinical evidence, drug information and appropriate patient selection for GLP-1 use

PA Sub-Categories: GLP-1 Prime Article: Stories
Prime presents at: GLP-1 Agonists + Food is Medicine: A New Recipe for Success in Treating Obesity? A Briefing for Congress on Sept. 11

Event on Sept. 11 in Washington D.C. will feature the latest information on using GLP-1s to tackle the obesity epidemic.

PA Sub-Categories: GLP-1 Prime Article: Events